Please join the Society for Maternal-Fetal Medicine for a virtual briefing on how a better understanding of the safety and efficacy of medications used during pregnancy can improve maternal and infant health outcomes.

Nearly 90% of pregnant women use at least one medication during pregnancy, yet most drug labels lack pregnancy-specific safety or efficacy data, leaving clinicians and patients to make critical decisions without robust evidence.

This briefing will examine the gaps driving this problem, highlight federal initiatives addressing them, and discuss bipartisan legislative solutions to improve data generation and ensure that pregnant and lactating patients have access to safe, effective treatments.